Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
8730 | 1224 | 35.3 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
405 | 3 | BACTERIORHODOPSIN//G PROTEIN COUPLED RECEPTOR//G PROTEIN | 29641 |
1079 | 2 | BETA3 ADRENOCEPTOR//ADENYLYL CYCLASE//G PROTEIN | 9902 |
8730 | 1 | BETA3 ADRENOCEPTOR//BRL 37344//ATYPICAL BETA ADRENOCEPTORS | 1224 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BETA3 ADRENOCEPTOR | authKW | 3386130 | 16% | 69% | 196 |
2 | BRL 37344 | authKW | 1149523 | 5% | 79% | 58 |
3 | ATYPICAL BETA ADRENOCEPTORS | authKW | 922986 | 3% | 100% | 37 |
4 | BETA 3 ADRENERGIC RECEPTOR | authKW | 577909 | 5% | 35% | 66 |
5 | CGP 12177 | authKW | 433952 | 3% | 46% | 38 |
6 | CGP12177A | authKW | 400513 | 1% | 94% | 17 |
7 | BUPRANOLOL | authKW | 389460 | 2% | 71% | 22 |
8 | CL 316 243 | authKW | 366687 | 2% | 70% | 21 |
9 | SR59230A | authKW | 327686 | 1% | 77% | 17 |
10 | BETA3 ADRENOCEPTOR AGONIST | authKW | 324266 | 2% | 50% | 26 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 8750 | 49% | 0% | 604 |
2 | Chemistry, Medicinal | 950 | 9% | 0% | 109 |
3 | Physiology | 597 | 8% | 0% | 104 |
4 | Endocrinology & Metabolism | 435 | 8% | 0% | 103 |
5 | Nutrition & Dietetics | 156 | 4% | 0% | 44 |
6 | Urology & Nephrology | 103 | 3% | 0% | 42 |
7 | Cardiac & Cardiovascular System | 88 | 5% | 0% | 57 |
8 | Chemistry, Organic | 67 | 5% | 0% | 62 |
9 | Gastroenterology & Hepatology | 42 | 3% | 0% | 32 |
10 | Medicine, Research & Experimental | 36 | 3% | 0% | 40 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHYSIOPATHOL PHARMACOL CELLULAI MOL | 59379 | 1% | 24% | 10 |
2 | RED CROSS HOSP GUANGZHOU CITY | 57015 | 0% | 57% | 4 |
3 | UPSP SSBR | 49891 | 0% | 100% | 2 |
4 | MOL PHARMACOL IMMUNOL RHEUMATOL | 44900 | 0% | 60% | 3 |
5 | CARDIOVASC PHYSIOPATHOL PHARMACOL | 33255 | 0% | 33% | 4 |
6 | PHARMACOL MICROBIOL S | 25648 | 0% | 17% | 6 |
7 | 195 ROUTE ESPAGNE | 24946 | 0% | 100% | 1 |
8 | 22 RUE MECHAIN | 24946 | 0% | 100% | 1 |
9 | 37 ALLEES JULES GUESDE | 24946 | 0% | 100% | 1 |
10 | ADF FARMACOL FARMACOTHER IE | 24946 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BRITISH JOURNAL OF PHARMACOLOGY | 18562 | 9% | 1% | 115 |
2 | NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 8288 | 4% | 1% | 45 |
3 | EUROPEAN JOURNAL OF PHARMACOLOGY | 5183 | 6% | 0% | 77 |
4 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 4335 | 5% | 0% | 61 |
5 | JOURNAL OF AUTONOMIC PHARMACOLOGY | 3576 | 1% | 1% | 11 |
6 | INTERNATIONAL JOURNAL OF OBESITY | 2450 | 2% | 0% | 26 |
7 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2121 | 4% | 0% | 47 |
8 | MOLECULAR PHARMACOLOGY | 1962 | 2% | 0% | 28 |
9 | JAPANESE JOURNAL OF PHARMACOLOGY | 1816 | 1% | 0% | 18 |
10 | CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 1425 | 2% | 0% | 20 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BETA3 ADRENOCEPTOR | 3386130 | 16% | 69% | 196 | Search BETA3+ADRENOCEPTOR | Search BETA3+ADRENOCEPTOR |
2 | BRL 37344 | 1149523 | 5% | 79% | 58 | Search BRL+37344 | Search BRL+37344 |
3 | ATYPICAL BETA ADRENOCEPTORS | 922986 | 3% | 100% | 37 | Search ATYPICAL+BETA+ADRENOCEPTORS | Search ATYPICAL+BETA+ADRENOCEPTORS |
4 | BETA 3 ADRENERGIC RECEPTOR | 577909 | 5% | 35% | 66 | Search BETA+3+ADRENERGIC+RECEPTOR | Search BETA+3+ADRENERGIC+RECEPTOR |
5 | CGP 12177 | 433952 | 3% | 46% | 38 | Search CGP+12177 | Search CGP+12177 |
6 | CGP12177A | 400513 | 1% | 94% | 17 | Search CGP12177A | Search CGP12177A |
7 | BUPRANOLOL | 389460 | 2% | 71% | 22 | Search BUPRANOLOL | Search BUPRANOLOL |
8 | CL 316 243 | 366687 | 2% | 70% | 21 | Search CL+316+243 | Search CL+316+243 |
9 | SR59230A | 327686 | 1% | 77% | 17 | Search SR59230A | Search SR59230A |
10 | BETA3 ADRENOCEPTOR AGONIST | 324266 | 2% | 50% | 26 | Search BETA3+ADRENOCEPTOR+AGONIST | Search BETA3+ADRENOCEPTOR+AGONIST |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | URSINO, MG , VASINA, V , RASCHI, E , CREMA, F , DE PONTI, F , (2009) THE BETA(3)-ADRENOCEPTOR AS A THERAPEUTIC TARGET: CURRENT PERSPECTIVES.PHARMACOLOGICAL RESEARCH. VOL. 59. ISSUE 4. P. 221 -234 | 126 | 79% | 67 |
2 | VRYDAG, W , MICHEL, MC , (2007) TOOLS TO STUDY BETA(3)-ADRENOCEPTORS.NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. VOL. 374. ISSUE 5-6. P. 385-398 | 98 | 82% | 40 |
3 | MICHEL, MC , KORSTANJE, C , (2016) BETA(3)-ADRENOCEPTOR AGONISTS FOR OVERACTIVE BLADDER SYNDROME: ROLE OF TRANSLATIONAL PHARMACOLOGY IN A REPOSITIONING CLINICAL DRUG DEVELOPMENT PROJECT.PHARMACOLOGY & THERAPEUTICS. VOL. 159. ISSUE . P. 66 -82 | 121 | 52% | 1 |
4 | SAWA, M , HARADA, H , (2006) RECENT DEVELOPMENTS IN THE DESIGN OF ORALLY BIOAVAILABLE BETA(3)-ADRENERGIC RECEPTOR AGONISTS.CURRENT MEDICINAL CHEMISTRY. VOL. 13. ISSUE 1. P. 25-37 | 75 | 89% | 27 |
5 | MOENS, AL , YANG, RH , WATTS, VL , BAROUCH, LA , (2010) BETA 3-ADRENORECEPTOR REGULATION OF NITRIC OXIDE IN THE CARDIOVASCULAR SYSTEM.JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. VOL. 48. ISSUE 6. P. 1088 -1095 | 71 | 66% | 23 |
6 | ROZEC, B , GAUTHIER, C , (2006) BETA(3)-ADRENOCEPTORS IN THE CARDIOVASCULAR SYSTEM: PUTATIVE ROLES IN HUMAN PATHOLOGIES.PHARMACOLOGY & THERAPEUTICS. VOL. 111. ISSUE 3. P. 652-673 | 93 | 48% | 101 |
7 | CERNECKA, H , SAND, C , MICHEL, MC , (2014) THE ODD SIBLING: FEATURES OF BETA(3)-ADRENOCEPTOR PHARMACOLOGY.MOLECULAR PHARMACOLOGY. VOL. 86. ISSUE 5. P. 479 -484 | 45 | 75% | 14 |
8 | GIACOBINO, JP , (1995) BETA(3)-ADRENOCEPTOR - AN UPDATE.EUROPEAN JOURNAL OF ENDOCRINOLOGY. VOL. 132. ISSUE 4. P. 377-385 | 67 | 85% | 93 |
9 | IMBROGNO, S , GATTUSO, A , MAZZA, R , ANGELONE, T , CERRA, MC , (2015) BETA(3)-AR AND THE VERTEBRATE HEART: A COMPARATIVE VIEW.ACTA PHYSIOLOGICA. VOL. 214. ISSUE 2. P. 158 -175 | 64 | 51% | 1 |
10 | STROSBERG, AD , (1997) STRUCTURE AND FUNCTION OF THE BETA(3)-ADRENERGIC RECEPTOR.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. VOL. 37. ISSUE . P. 421 -450 | 54 | 78% | 169 |
Classes with closest relation at Level 1 |